Fluoresceine-Oxybuprocaine SDU Faure, Augentropfen
Recall
|
Medicines
|
12/12/2023
The marketing authorisation holder informed its customers on December 12, 2023, that the mentioned batches could be potentially non-sterile. The affected batches are being recalled as a precautionary measure. The medicinal product is authorised in Switzerland and placed on the market in Austria under the Austrian Act on the Import of Medicinal Products.
| Name of the medicinal product | Fluoresceine-Oxybuprocaine SDU Faure, Augentropfen |
|---|---|
| Marketing authorisation number(s) | 54756 (CH) |
| CIP code | 3865551 |
| Marketing authorisation holder | OmniVision AG Schweiz |
| Distributor | WABOSAN Arzneimittelvertriebs GmbH |
| Batch number(s) | Batch, Expiry Date, 1S57, 01/2025 7S81, 06/2025 |
| Classification of the recall | 1 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-4568 |
Further inquiry note
Page last modified:
12/12/2023